IDGT: Concentrated ETF In Internet Infrastructure — Positive

IDGT   Seeking Alpha — February 11, 2025

iShares U.S. Digital Infrastructure and Real Estate ETF (IDGT) focuses on communication equipment, tower REITs, and data center REITs, with a concentrated portfolio. IDGT has excellent cash flow characteristics but shows lower historical returns and higher volatility compared to broad market and sector benchmarks. IDGT outperforms other digital infrastructure ETFs due to higher technology sector exposure.

image for news IDGT: Concentrated ETF In Internet Infrastructure

DoorDash Beats on Revenue, Misses on EPS — Positive

DASH   The Motley Fool — February 11, 2025

DoorDash (DASH 0.24%), a leading food delivery and logistics company, released its fourth-quarter earnings on Feb. 11. The company reported strong revenue growth to $2.87 billion, about 1% higher than analysts' estimates of $2.84 billion.

image for news DoorDash Beats on Revenue, Misses on EPS

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ: NTLA) between July 30, 2024 to January 8, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Marcos Gonzalez v.

image for news SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Intellia Therapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of April 14, 2025

TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- McEwen Copper Inc., a subsidiary of McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), is pleased to announce that its subsidiary Andes Corporación Minera S.A., has applied for admission of the Los Azules copper project to Argentina's Large Investment Incentive Regime (“RIGI”).

image for news Los Azules Requests Admission to Argentina's Incentive Regime for Large Investments

Gain comes as a result of early investment in Simple Mills made by Lifeway in 2015 MORTON GROVE, Ill. , Feb. 11, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, expects to realize approximately $5 million of net profit as a result of the recently announced sale of Simple Foods to Flowers Foods.

image for news LIFEWAY FOODS EXPECTS TO REALIZE $5 MILLION NET GAIN FROM SALE OF SIMPLE FOODS TO FLOWERS FOODS

Cboe Global Markets Declares First-Quarter 2025 Dividend — Neutral

CBOE   PRNewsWire — February 11, 2025

CHICAGO , Feb. 11, 2025 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced its Board of Directors has declared a quarterly cash dividend of $0.63 per share of common stock for the first quarter of 2025. The first-quarter 2025 dividend is payable on March 14, 2025, to stockholders of record as of February 28, 2025.

image for news Cboe Global Markets Declares First-Quarter 2025 Dividend

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ModivCare Inc. (NASDAQ:MODV) between November 3, 2022 and September 15, 2024, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased ModivCare securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, LEADING INVESTOR COUNSEL, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MODV

Copa Holdings Announces Monthly Traffic Statistics for January 2025 — Neutral

CPA   GlobeNewsWire — February 11, 2025

PANAMA CITY, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Copa Holdings, S.A. (NYSE: CPA) today released preliminary passenger traffic statistics for January 2025:

image for news Copa Holdings Announces Monthly Traffic Statistics for January 2025

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review top-line data from the global Phase 2b RENOIR clinical trial of investigational rosnilimab, a depleter and agonist of PD-1+ T cells, for moderate-to-severe rheumatoid arthritis on Wednesday, Feb. 12, 2025, at 8:30am ET / 5:30am PT.

image for news Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025

Jerash Holdings (US), Inc. (JRSH) Q3 2025 Earnings Call Transcript — Neutral

JRSH   Seeking Alpha — February 11, 2025

Jerash Holdings (US), Inc. (NASDAQ:JRSH ) Q3 2025 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Roger Pondel - IR, PondelWilkinson Sam Choi - Chairman & CEO Eric Tang - Executive Director Gilbert Lee - CFO Conference Call Participants Mark Argento - Lake Street Michael Baker - D.A. Davidson Igor Novgorodtsev - Lares Capital Operator Good morning.

image for news Jerash Holdings (US), Inc. (JRSH) Q3 2025 Earnings Call Transcript

WK Kellogg Co (KLG) Q4 2024 Earnings Call Transcript — Neutral

KLG   Seeking Alpha — February 11, 2025

WK Kellogg Co (NYSE:KLG ) Q4 2024 Earnings Conference Call February 11, 2025 9:30 AM ET Company Participants Karen Duke - VP of Finance & IR Gary Pilnick - Chairman and CEO Dave McKinstray - CFO Conference Call Participants Andrew Lazar - Barclays Peter Galbo - Bank of America Kenneth Goldman - JPMorgan Max Gumport - BNP Paribas Matthew Smith - Stifel David Palmer - Evercore ISI Robert Dickerson - Jefferies Robert Moskow - TD Securities Operator Hello, everyone, and welcome to the WK Kellogg Fourth Quarter 2024 Earnings Call. My name is Lydia, and I'll be your operator today.

image for news WK Kellogg Co (KLG) Q4 2024 Earnings Call Transcript

TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) (the “Company”) is pleased to announce it has closed its previously announced offering of 5.25% convertible senior notes due 2030 (the “Notes”) in an aggregate principal amount of $110 million (the “Offering”), which includes the upsized offering of $95 million and the exercise in full of the $15 million option granted to the initial purchasers of the Notes. All amounts are in United States Dollars.

image for news McEwen Mining Completes Upsized $110 Million Offering of Convertible Senior Unsecured Notes

– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data from Phase 2b ReNeu trial, which showed GOMEKLI treatment resulted in robust ORR, deep and durable reductions in tumor volume, and a manageable safety profile – – SpringWorks granted rare pediatric disease priority review voucher by the FDA – Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/8eb8effc-49a5-4b24-911f-d3e6dfa9c8a9 https://www.globenewswire.com/NewsRoom/AttachmentNg/f1041678-3f79-43b7-a101-2390fb8cb86b https://www.globenewswire.com/NewsRoom/AttachmentNg/7d8cb318-e5f8-4944-8736-24cb19a5dec9 https://www.globenewswire.com/NewsRoom/AttachmentNg/072d748b-3237-48ad-8d83-1c6c23dda65f STAMFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that …

image for news SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

Vornado Realty Trust (VNO) Q4 2024 Earnings Call Transcript — Neutral

VNO   Seeking Alpha — February 11, 2025

Vornado Realty Trust (NYSE:VNO ) Q4 2024 Earnings Conference Call February 11, 2025 10:00 AM ET Company Participants Steven Borenstein - Senior Vice President & Corporate Counsel Steven Roth - Chairman & Chief Executive Officer Michael Franco - President & Chief Financial Officer Glen Weiss - Executive Vice President, Office Leasing & Co-Head, Real Estate Conference Call Participants Steve Sakwa - Evercore ISI John Kim - BMO Capital Markets Jeff Spector - Bank of America Dylan Burzinski - Green Street Capital Floris van Dijkum - Compass Point Michael Griffin - Citi Vikram Malhotra - Mizuho Securities Michael Lewis - Truist …

image for news Vornado Realty Trust (VNO) Q4 2024 Earnings Call Transcript

Streaming giant Netflix Inc NFLX has opened a new restaurant experience in Las Vegas as part of its continuing efforts to diversify its revenue thanks to loyal fan bases.

image for news Netflix Stock Near All-Time Highs: New Las Vegas Restaurant With Food Inspired By Stranger Things, Squid Game & More Could Diversify Revenue

UTES: This Could Change Everything (Downgrade) — Neutral

UTES   Seeking Alpha — February 11, 2025

AI-driven energy demands have boosted utility stocks, but DeepSeek's efficient AI approach questions future growth projections, impacting the Virtus Reaves Utilities ETF (UTES). UTES saw significant gains in 2024, led by top holdings like Constellation Energy and Vistra, but current high valuations may not be sustainable if projections change. Environmental and regulatory challenges complicate utility expansions, making it difficult for UTES to find alternative growth opportunities within its top holdings.

image for news UTES: This Could Change Everything (Downgrade)

Kellogg Looks to Donut Holes to Plug Leaks in US Market Share — Positive

KLG   Investopedia — February 11, 2025

Facing a drop in US market share, WK Kellogg (KLG) hopes to glaze over the issue.

image for news Kellogg Looks to Donut Holes to Plug Leaks in US Market Share

Major U.S. equities indexes were mixed and little changed as Federal Reserve Chair Jerome Powell began his two-day stint of testimony before Congress, stressing that the central bank will maintain a cautious approach.

image for news S&P 500 Gains and Losses Today: DuPont Stock Pops as Electronics Drive Earnings Beat

Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade — Positive

AXSM  TEVA   Seeking Alpha — February 11, 2025

Axsome Therapeutics, Inc.'s stock has surged over 30% since my last “Hold” rating, driven by key catalysts like the litigation settlement with Teva Pharmaceuticals, announced today. Axsome's Auvelity and Sunosi are crucial, with Auvelity expected to generate over 75% of 2025 revenues; as such, today's news is a significant win. Despite high competition in MDD and other markets, Axsome's pipeline, including AXS-07 and AXS-12, shows potential for substantial revenue growth.

image for news Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade

NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS